Mayne Pharma Sues Sun Pharma Over Patent Infringement
Company Announcements

Mayne Pharma Sues Sun Pharma Over Patent Infringement

Mayne Pharma Group (AU:MYX) has released an update.

Mayne Pharma Group has initiated a patent infringement lawsuit against Sun Pharmaceutical over the alleged infringement of patents related to IMVEXXY, a medication for menopause-related vaginal pain. The lawsuit was filed following Sun Pharma’s application to market a generic version of IMVEXXY, triggering a 30-month stay on FDA approval. Mayne Pharma, a leader in women’s healthcare, vows to defend its intellectual property to support its patients and product franchise.

For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskMayne Pharma Hosts Investor Webinar on US Business Segments
TipRanks Australian Auto-Generated NewsdeskMayne Pharma to Highlight Growth in US Health Sectors
TipRanks Australian Auto-Generated NewsdeskInsignia Financial Acquires Stake in Mayne Pharma
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App